» Articles » PMID: 16096642

Transforming Activity of Fbxo7 is Mediated Specifically Through Regulation of Cyclin D/cdk6

Overview
Journal EMBO J
Date 2005 Aug 13
PMID 16096642
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

D cyclins (D1, D2 and D3) and their catalytic subunits (cyclin-dependent kinases cdk4 and cdk6) have a facilitating, but nonessential, role in cell cycle entry. Tissue-specific functions for D-type cyclins and cdks have been reported; however, the biochemical properties of these kinases are indistinguishable. We report that an F box protein, Fbxo7, interacted with cellular and viral D cyclins and distinguished among the cdks that bind D-type cyclins, specifically binding cdk6, in vitro and in vivo. Fbxo7 specifically regulated D cyclin/cdk6 complexes: Fbxo7 knockdown decreased cdk6 association with cyclin and its overexpression increased D cyclin/cdk6 activity and E2F activity. Fbxo7 interacted with p27, but its enhancement of cyclin D/cdk6 activity was p21/p27 independent. Fbxo7 overexpression transformed murine fibroblasts, rendering them tumorigenic in athymic nude mice. Transformed phenotypes were dependent on cdk6, as knockdown of cdk6 reversed them. Fbxo7 was highly expressed in epithelial tumors, but not in normal tissues, suggesting that it may have a proto-oncogenic role in human cancers.

Citing Articles

Comprehensive genome-wide analysis of genetic loci and candidate genes associated with litter traits in purebred Berkshire pigs of Korea.

Park J Anim Biosci. 2024; 37(10):1702-1711.

PMID: 39164087 PMC: 11366516. DOI: 10.5713/ab.24.0046.


FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma.

Luo L, Wu X, Fan J, Dong L, Wang M, Zeng Y Nat Commun. 2024; 15(1):4790.

PMID: 38839752 PMC: 11153525. DOI: 10.1038/s41467-024-49087-2.


Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma.

Webster N, Kumar D, Wu P Sci Rep. 2024; 14(1):2500.

PMID: 38291075 PMC: 10828381. DOI: 10.1038/s41598-024-52237-7.


FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.

Li S, Chen Y, Xie Y, Zhan H, Zeng Y, Zeng K Adv Sci (Weinh). 2023; 10(33):e2303561.

PMID: 37822160 PMC: 10667838. DOI: 10.1002/advs.202303561.


A Diagnostic Model Using Exosomal Genes for Colorectal Cancer.

Lei T, Zhang Y, Wang X, Liu W, Feng W, Song W Front Genet. 2022; 13:863747.

PMID: 35910195 PMC: 9334773. DOI: 10.3389/fgene.2022.863747.


References
1.
Shcherbik N, Haines D . Ub on the move. J Cell Biochem. 2004; 93(1):11-9. DOI: 10.1002/jcb.20130. View

2.
Sherr C, Roberts J . CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999; 13(12):1501-12. DOI: 10.1101/gad.13.12.1501. View

3.
Matsushime H, Quelle D, Shurtleff S, Shibuya M, Sherr C, Kato J . D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol. 1994; 14(3):2066-76. PMC: 358567. DOI: 10.1128/mcb.14.3.2066-2076.1994. View

4.
Schmidt E, Ichimura K, Reifenberger G, Collins V . CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res. 1994; 54(24):6321-4. View

5.
MORGAN D . Principles of CDK regulation. Nature. 1995; 374(6518):131-4. DOI: 10.1038/374131a0. View